These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3877147)

  • 1. N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases acetylcholine and decreases dopamine in mouse striatum: both responses are blocked by anticholinergic drugs.
    Hadjiconstantinou M; Cavalla D; Anthoupoulou E; Laird HE; Neff NH
    J Neurochem; 1985 Dec; 45(6):1957-9. PubMed ID: 3877147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl.
    Saitoh T
    J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
    Ricaurte GA; Langston JW; DeLanney LE; Irwin I; Brooks JD
    Neurosci Lett; 1985 Sep; 59(3):259-64. PubMed ID: 3932903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice.
    Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC
    Neuropharmacology; 1984 Jun; 23(6):711-3. PubMed ID: 6611514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine blocks the dopamine depletion induced by MPTP.
    Mayer RA; Jarvis MF; Wagner GC
    Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):145-8. PubMed ID: 3875884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice.
    Bhargava HN; Perlow MJ
    Toxicol Lett; 1988 Mar; 40(3):219-24. PubMed ID: 3258448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Finnegan KT; Irwin I; Delanney LE; Ricaurte GA; Langston JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1144-51. PubMed ID: 3498815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):17-25. PubMed ID: 3873102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Donnan GA; Willis GL; Kaczmarczyk SJ; Rowe P
    J Neurol Sci; 1987 Feb; 77(2-3):185-91. PubMed ID: 3493329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.
    Reinhard JF; Miller DB; O'Callaghan JP
    Neurosci Lett; 1988 Dec; 95(1-3):246-51. PubMed ID: 3265770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its metabolite 1-methyl-4-phenylpyridinium ion (MPP+) decrease dopamine and increase acetylcholine in the mouse neostriatum.
    Cavalla D; Hadjiconstantinou M; Laird HE; Neff NH
    Neuropharmacology; 1985 Jun; 24(6):585-6. PubMed ID: 3875055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of depletion of striatal dopamine by phenylpiperidine analgesics.
    Baldessarini RJ; Neumeyer JL
    N Engl J Med; 1986 Mar; 314(10):649. PubMed ID: 3484802
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparations.
    Heikkila RE; Youngster SK; Manzino L; Cabbat FS; Duvoisin RC
    J Neurochem; 1985 Jan; 44(1):310-3. PubMed ID: 3871120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
    Mayer RA; Walters AS; Heikkila RE
    Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain.
    Pileblad E; Nissbrandt H; Carlsson A
    J Neural Transm; 1984; 60(3-4):199-203. PubMed ID: 6084705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
    Mayer RA; Kindt MV; Heikkila RE
    J Neurochem; 1986 Oct; 47(4):1073-9. PubMed ID: 3489072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice.
    Saitoh T; Niijima K; Mizuno Y
    J Neurol Sci; 1987 Feb; 77(2-3):229-35. PubMed ID: 3493330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral versus parenteral efficacy of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): differential effects on depletion of heart norepinephrine and of striatal dopamine in mice.
    Fuller RW; Hemrick-Luecke SK
    Biochem Pharmacol; 1987 Mar; 36(6):789-92. PubMed ID: 3494450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.